Sign in

CIK 0001357459

  • Non-accelerated filer
  • Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522007292
Phone
+1 858-704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
Open-market buys, last 90 days
$28,800
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Williams Donald Allen +$29K Director 1 filing

Reading 87 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +40 40
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +516 516
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +27 27
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +325 325
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +293 293
2021-04-27 Diaz Stephanie Director Grant or award · Stock Option (Right to Buy) +10,203 10,203
2021-04-27 Diaz Stephanie Director Grant or award · Stock Option (Right to Buy) +4,406 4,406
2021-04-27 Dawson Michael John Chief Medical Officer Grant or award · Stock Option (Right to Buy) +5,438 5,438
2021-04-27 Dawson Michael John Chief Medical Officer Grant or award · Stock Option (Right to Buy) +20,391 20,391
2021-04-27 Dawson Michael John Chief Medical Officer Grant or award · Stock Option (Right to Buy) +5,084 5,084
2021-04-27 Dawson Michael John Chief Medical Officer Grant or award · Stock Option (Right to Buy) +1,962 1,962
2021-04-27 Dawson Michael John Chief Medical Officer Grant or award · Stock Option (Right to Buy) +2,800 2,800
2021-04-01 Mazzo David J Director Grant or award · Restricted Stock Units +6,000 6,000
2021-04-01 GRAY MARY ANN Director Grant or award · Restricted Stock Units +6,000 6,000
2021-04-01 Csimma Cristina Director Grant or award · Restricted Stock Units +6,000 6,000
2021-04-01 Wei Binxian Director Grant or award · Restricted Stock Units +6,000 6,000
2020-04-03 Wei Binxian Director Grant or award · Restricted Stock Units +6,000 6,000
2020-04-03 Csimma Cristina Director Grant or award · Restricted Stock Units +6,000 6,000
2020-04-03 GRAY MARY ANN Director Grant or award · Restricted Stock Units +6,000 6,000
2020-04-03 Mazzo David J Director Grant or award · Restricted Stock Units +6,000 6,000

Page 16 of 21 · 409 trades